Introduction
============

Decompressive craniectomy (DC) is a treatment option for refractory intracranial hypertension that involves removing a portion of the skull to alleviate swelling.[@b1-ndt-10-695] Harvey Cushing was the first to describe this technique, and for decades it has been mainly used in the treatment of ischemic stroke and traumatic brain injury.[@b2-ndt-10-695]--[@b5-ndt-10-695] Despite the reduction of morbidity and mortality associated with this surgical technique, many patients experience early- and late-onset complications such as herniation through the edges of the craniectomy (51%) resulting in brain injury (6% to 58%),[@b6-ndt-10-695] subdural hygroma (16% to 62%),[@b6-ndt-10-695]--[@b8-ndt-10-695] hydrocephalus (2% to 29%),[@b9-ndt-10-695],[@b10-ndt-10-695] motor impairment,[@b9-ndt-10-695],[@b11-ndt-10-695] infection,[@b10-ndt-10-695] and trephine syndrome (TS) (26%).[@b7-ndt-10-695]

Patients with large skull defects are particularly at risk of developing TS, also known as "sinking skin flap syndrome" or "trephined motor syndrome". This syndrome is characterized by headache, dizziness, alterations in behavior and mood, seizures, fatigue, motor deficits, and language disturbances.[@b12-ndt-10-695]--[@b14-ndt-10-695] To date, little is known about the pathophysiological mechanisms underlying this syndrome; however, some authors have hypothesized that abnormal brain pulsatility,[@b15-ndt-10-695] the effect of atmospheric pressure over the bone defect,[@b13-ndt-10-695],[@b16-ndt-10-695]--[@b18-ndt-10-695] changes in cerebrospinal fluid and venous drainage dynamics,[@b19-ndt-10-695]--[@b22-ndt-10-695] and changes in blood flow and metabolism may all contribute.[@b23-ndt-10-695]--[@b33-ndt-10-695]

Case reports and clinical series published to date suggest improvement in neurological deficits, cognitive function, and brain hemodynamics after bone replacement (cranioplasty),[@b34-ndt-10-695]--[@b40-ndt-10-695] suggesting potential benefits of this procedure in respect to cognitive aspects. However, little is known about cognitive changes after cranioplasty. The purpose of this paper is to report a comprehensive description of cognitive and hemodynamic changes seen in a patient after cranioplasty.

Materials and methods
=====================

Clinical assessment protocol
----------------------------

A patient clinically diagnosed with TS was selected to a prospective protocol. Demographic data, clinical signs, and symptoms were recorded after the completion of a systematic questionnaire regarding the most common symptoms in patients with skull defects. The battery of neuropsychological tests consisted of logical memory and visual reproduction (subtests of the Wechsler Memory Scale -- Revised); the Rey Audio-Verbal Learning Test (RAVLT); the Controlled Oral Word Association Test (COWAT-FAS); the Verbal Fluency Test -- Animal Category, the Victoria Stroop Test (VST); digits, cubes, arithmetic, sequence of numbers and letters; the Working Memory Index from the Wechsler Adult Intelligence Scale (WMI-WAIS); the Wechsler Memory Scale (WMS) and Wechsler Adult Intelligence Scale; the Trail Making Test A (TMTA) and B (TMTB); the Pfeffer Outpatient Disability Scale (POD); the Rey Complex Figure Test; the Beck Depression Inventory (BDI); the Beck Anxiety Inventory (BAI); the Beck Hopelessness Scale (BHS); the Lipp's Inventory of Stress Symptoms for adults (ISSL); and the mini-mental state examination (MMSE). The modified Rankin Scale (mRS) and Barthel Index (BI) were recorded to evaluate global functional status. All neuropsychological tests, and the mRS and BI were performed 1 day before cranioplasty. These assessments were repeated 6 months after cranioplasty.

In order to minimize the effects of cumulative learning due to retesting of RAVLT, List A and B, and the recognition test, the words used in the preoperative assessment were replaced by others in the postoperative evaluations. The words used in the tests after surgery were similar with respect to preoperative testing in terms of size (number of letters) and frequency of use by the population. The patient did not undergo a cognitive rehabilitation program in the period between preoperative and postoperative clinical assessments.

Cerebral hemodynamic assessment protocol
----------------------------------------

The patient was studied with transcranial Doppler ultrasonography (TCD) coupled to a 2-MHz transducer (DWL Doppler Box™, Compumedics Germany GmbH, Singen, Germany) to assess cerebral blood flow velocity from both middle cerebral arteries before and 15 days after cranioplasty. The measurements were conducted while the patient was at rest, in the supine and sitting positions.

Computed tomography (CT) brain perfusion was also performed before and 30 days after cranioplasty. The parameters of cerebral blood flow (CBF), cerebral blood volume, and mean transit time in four symmetrical brain regions of interest in each hemisphere were evaluated ([Figure 1](#f1-ndt-10-695){ref-type="fig"}). An Ingenuity Flex[@b32-ndt-10-695] CT scanner (Philips Healthcare, DA Best, the Netherlands) with 32 channels was used. The scan was based on continuous acquisition at 80 kVp 200 mA for a duration of 40 seconds, allowing a total of 240 images to be obtained; contrast enhancement medium was administered at a rate of 5 mL/second. The CT data were processed using Philips iSite PACS software (Philips Healthcare).

Ethical considerations
----------------------

This case study was approved by the ethics committee of our institution (CAPPESQ -- University of São Paulo Medical School) and informed consent was obtained from the patient or his caregiver.

Literature review
-----------------

We systematically searched the PubMed database up to September 2013 using the following search terms and combinations: "cranioplasty", "trephined syndrome", "sinking skin flap syndrome", "neurological deficits", "cerebral decompression", "brain decompression", and "decompressive craniotomy". Reference lists of recovered articles were examined for additional suitable papers. The "Related Articles" feature in PubMed was also used for all selected studies to maximize the probability of locating additional relevant studies. The inclusion criteria for the review was any study including case reports and case series describing clinical improvements after cranioplasty such as improvement of symptoms related to TS or even reversal of neurological deficits and cognitive disturbances. We excluded studies describing only cerebral hemodynamic changes and papers in which interventions other than cranioplasty had been performed ([Table 2](#t2-ndt-10-695){ref-type="table"}). Two observers (RLA and WSP) independently reviewed the results of the PubMed search and selected the articles to be included in the analysis; discrepancies were resolved by consensus. We found 1,996 articles, and after matching the inclusion criteria, 29 articles were selected. All studies were case series or case reports.

Case report
===========

A 44-year-old woman with a history of antiphospholipid antibody syndrome (coumarin user) presented with traumatic brain injury after falling to the ground. Upon admission, she scored 12 points on the Glasgow Coma Scale, and a CT scan depicted a massive left frontotemporal subdural hematoma and brain midline shift. The patient underwent a craniotomy to remove the clot and was discharged 2 weeks later. She was conscious and oriented, and exhibited no motor deficit except for a slight difficulty in speaking. Four weeks later, she developed a wound infection. She was treated with antibiotics and the affected bone had to be removed.

The patient was reassessed 8 months later. The bone defect was 8.2 cm × 5.3 cm in size, and the scalp had sunk 2.2 cm from the surface of the skull. A CT scan showed no shift of brain structures, but sulci were enfaced next to the bone defect ([Figure 2](#f2-ndt-10-695){ref-type="fig"}). The patient presented with headache, tinnitus, dizziness with head movements, incision discomfort, and difficulty in speech. There were no motor deficits, and she received 29 points on the MMSE. The patient scored 2 points on the mRS (ranging 0--6) and 100 points on the BI (ranging 0--100). The patient underwent cranioplasty with methyl methacrylate and was discharged uneventfully on the second postoperative day.

Six months after surgery, the patient reported complete resolution of symptoms, without changes in motor examination, and a subjective report of improvement in verbal fluency. Neuropsychological assessment before and after cranioplasty showed improvement in memory capacity, language, executive functions, and activities of daily living ([Table 1](#t1-ndt-10-695){ref-type="table"}). Postoperative MMSE showed a slight variation (down 1 point). No changes were observed in BI and mRS.

Regarding the cerebral hemodynamic changes, postoperative TCD showed a 20% and 16% increase in the cerebral blood flow velocity in the middle cerebral artery in the supine and the sitting positions, respectively. There was no significant increment of CBF velocity on the contralateral middle cerebral artery.

Perfusion CT study revealed an increase in CBF: 18 to 58 mL/100 g/minute ipsilateral to the cranioplasty and 19 to 70 mL/100 g/minute on the contralateral side. Interestingly, there was a reduction in the mean transit time on both sides: 14.7 to 5.2 seconds (ipsilateral to the cranioplasty) and 13.6 to 4.8 seconds (contralateral side). The increment in cerebral blood volume was less evident: 4.03 to 5.11 mL/100 g (ipsilateral to the cranioplasty) and from 4.34 to 5.46 mL/100 g (contralateral side). The values of blood pressure and heart rate were similar at the time of the tests ([Figure 3](#f3-ndt-10-695){ref-type="fig"}).

Discussion
==========

The findings of this case report indicate that a skull defect can lead to an objective neuropsychological impairment, not exclusively due to the primary injury. Generally, patients submitted to DC are at risk of death and, consequently, can present with a constellation of neurological symptoms. An implication of this study is that the replacement of the bone (which had been considered merely a matter of cosmesis for decades) may actually confer functional benefits to the patient. Although the first report describing the symptoms caused by the skull defect comes from 1939 (Grant and Norcross),[@b12-ndt-10-695] researchers have not investigated the late effects of DC and cranioplasty in much detail. Grant and Norcross[@b12-ndt-10-695] described the first clinical series of patients who underwent cranioplasty and presented with the syndrome of the trephined. Of the 83 operated patients, 43 had symptoms compatible with TS, and improvement occurred in approximately 25% of cases. The improvement in motor signs and symptoms was noted in 14% of patients. Despite the observation that there was cognitive improvement in three cases, there was no information about the variables used in cognitive assessment. Grantham and Landis[@b15-ndt-10-695] presented similar results in 1948, showing advance in 29% of TS patients and improvement of verbal fluency in some cases.

TS has been described in patients who develop progressive loss of hand strength contralateral to the skull defect in the late phase post-DC.[@b12-ndt-10-695]--[@b14-ndt-10-695] In 1977, Yamaura and Makino showed that patients with sinking skin at the site of bone defects can present with progressive motor deficit, reversible in 30% of cases after cranioplasty.[@b13-ndt-10-695] They found that regardless of the underlying disease that led to DC, patients who had more prominent concavity tended to develop motor deficits that could be reversed with cranioplasty. In addition, they observed improvement in neurological deficits in 30% of patients and correlated these findings with modification of standard electroencephalogram. These authors believed that the compressive effects of atmospheric pressure on the brain parenchyma led to neurological impairment, and that the risk of TS occurrence was higher in patients with large bone defects.[@b16-ndt-10-695],[@b20-ndt-10-695],[@b34-ndt-10-695],[@b41-ndt-10-695] Our patient presented with a significant "brain compression" that was totally reversed after the cranioplasty.

With the advent of techniques for assessing cerebral circulation, studies have shown reduced local cerebral blood flow associated with the compromised cerebral hemisphere. Richaud et al,[@b21-ndt-10-695] through examinations with inhaled xenon 133, showed a 15%--30% increase in cerebral perfusion and improvement in neurological deficit in approximately eight of 15 patients evaluated. Stiver et al in 2008[@b31-ndt-10-695] showed, through CT perfusion, a possible relationship between the development of neurological deficits and delayed worsening of cerebrospinal fluid circulation by facilitating the passage of liquor into the brain parenchyma adjacent to the previous contused areas. Winkler et al[@b24-ndt-10-695] used TCD to suggest improvement of cerebrovascular reactivity after cranioplasty, and that restoration of cerebral blood flow was related to improvement in glucose metabolism in the cerebral hemispheres, including areas contralateral to the bone defect. In this study, the mean increase in the rate of glucose metabolism (12.1% on the cranioplasty side and 4.5% on the contralateral side) was associated with a positive clinical prognosis and elevated satisfaction. Of the 13 patients enrolled, seven (53%) had reversal of hemiparesis, two (15%) of hemineglect, two (15%) of aphasia, and seven (53%) showed improvement in cognitive functions (not quantified) after cranioplasty. In our case, there was an increase in cerebral blood flow demonstrated by CT perfusion study and by TCD. However, despite reports of cognitive improvement, the data provided by publications continue to be more qualitative than quantitative.

Some authors claim that cranioplasty may result in improved cognition and neurological signs and symptoms of TS.[@b12-ndt-10-695],[@b24-ndt-10-695],[@b39-ndt-10-695],[@b42-ndt-10-695]--[@b47-ndt-10-695] Maeshima et al[@b26-ndt-10-695] used several scales (Word Fluency Test, Frontal Lobe Assessment Battery, Auditory Verbal Learning Test, Raven's Colored Progressive Matrices and Revised WAIS, MMSE, and Behavioral Inattention Test) to quantify cognitive improvement, correlating these findings with cerebral perfusion data. Likewise, Agner et al[@b48-ndt-10-695] showed improvement in neurocognitive analysis of 48.3% in the Cognistat scores (Neurobehavioral Cognitive Status Examination, which independently assess different aspects of language, the ability to perform complex constructions, memory, calculations, and reasoning) and of 32.95% in the EXIT interview (Executive Interview, assesses executive functions in the bedside) after cranioplasty.

In our case, the comparative results between the two neuropsychological assessments showed significant improvement in the task of verbal fluency by phonemic category of the COWAT-FAS, having initially received a lower score than expected for the level of schooling and, at a later point in time, scoring above average. It also highlighted better scores for the task of verbal fluency (semantic category of animals), episodic memory (logical memory), audio-verbal learning (RAVLT), information processing speed (TMTA, TMTB, and VST), and visual-constructive functions (copy of Rey Complex Figure Test and cubes).

Our patient attained similar performance with respect to visual memory, logical reasoning ability, and inhibitory control, while demonstrating worsening performance on the attentional tasks (digits, TMTA, TMTB), and occupational memory index (arithmetic, digits, and sequence of numbers and letters). The capacity to perform daily activities and emotional processing showed the most promising results. Taken together, these findings show us that improvement of symptoms and signs of TS, as well as cognitive impairment, could be related to an improvement in the hemodynamic brain patterns in both hemispheres. This report served as a pilot study of a prospective cohort study that includes the entire assessments described here, aiming to evaluate patients with large and small skull defects, due to traumatic or non-traumatic causes.

Conclusion
==========

Although it is difficult to draw conclusions from a single case report, our study provides additional evidence with respect to the possible pathophysiological mechanisms involved in TS, which can be related to a global hemodynamic dysfunction. Moreover, the benefits provided by the cranioplasty suggest that skull defects can also lead, in the long term, to neuropsychological impairments. Further work needs to be done to test these hypotheses with a larger sample size. Therefore, a prospective cohort study is being prepared to address the correlation between brain hemodynamics and clinical findings in such patients.
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![Computed tomography perfusion with four regions of interest selected in each cerebral hemisphere.\
**Note:** Three superficial regions and one positioned in the basal ganglia.\
**Abbreviations:** R, right; P, posterior.](ndt-10-695Fig1){#f1-ndt-10-695}

![Cranial computed tomography before performing cranioplasty.\
**Note:** We observed a significant depression of the skin flap with erasing wrinkles and superficial cortical compression.](ndt-10-695Fig2){#f2-ndt-10-695}

![Perfusion computed tomography before (top) and after (bottom) surgery showing the changes in the three parameters: CBF, CBV, and MTT.\
**Note:** In this image we can also see a restructuring of the cortical mantle of the left frontal region.\
**Abbreviations:** CBF, cerebral blood flow; CBV, cerebral blood volume; MTT, mean transit time.](ndt-10-695Fig3){#f3-ndt-10-695}

###### 

Neuropsychological assessment before and 6 months after cranioplasty

  ------------------------------------------------------------------------------------------------------------------
  Tests                                                          Results (preoperative)    Results (postoperative)
  -------------------------------------------------------------- ------------------------- -------------------------
  **Neuropsychological assessment**                                                        

  WMS -- Logical\                                                13; below average         24; below average
  Memory II (immediate)                                                                    

  WMS -- Logical\                                                8; below average          11; below average
  Memory II (delayed)                                                                      

  WMS -- VR (immediate)                                          1; below average          1; below average

  WMS -- VR (delayed)                                            1; below average          1; below average

  **RAVLT**                                                                                

  \(I\)                                                          2                         2

  \(II\)                                                         3                         4

  \(III\)                                                        9                         10

  \(IV\)                                                         7                         10

  \(V\)                                                          7 (below average)         12 (below average)

  (B list)                                                       5                         1

  \(VI\)                                                         4                         6

  \(VII\)                                                        4 (4.1; below average)    8 (2.3; below average)

  FAS-test                                                       23 (1.6; below average)   41 (0; average)

  Verbal fluency                                                 13 (1.8; below average)   17 (0.9; below average)

  Digit span forward                                             8; below average          5; below average

  Digit span backward                                            5; below average          4; below average

  TMTA                                                           0; not completed          3.1; below average

  TMTB                                                           0; not completed          9; below average

  Arithmetics                                                    6; below average          6; below average

  Sequencing                                                     6; below average          2; below average

  Stroop test I                                                  3; below average          4; below average

  Stroop test II                                                 6; below average          5; below average

  Stroop test III                                                1.3; below average        0.1; below average

  WMI-WAIS                                                       25; average               11; below average

  Cube copy test                                                 8; below average          16; average

  Complex rey figure[a](#tfn1-ndt-10-695){ref-type="table-fn"}   3.16; below average       1.1; average

  ISSL[b](#tfn2-ndt-10-695){ref-type="table-fn"}                 10/7/10                   2/4/4

  BDI                                                            17; mild                  5; minimal

  BAI                                                            12; mild                  8; minimal

  BHS                                                            0; minimal                0; minimal

  POD                                                            0; minimal                0; minimal
  ------------------------------------------------------------------------------------------------------------------

**Notes:**

The preoperative score was 3.16 times the standard deviation below the average of the expected score. The postoperative score was 1.1 time the standard deviation below the expected normal score, considering the average for this test.

Values shown are psychological symptoms/physical symptoms/psychological and physical symptoms.

**Abbreviations:** BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BHS, Beck Hopelessness Scale; FAS-Test, Controlled Oral Word Association Test (COWAT) -- FAS Test; ISSL, Lipp Inventory of Stress Symptoms; POD, Pfeffer Outpatient Disability Scale; RAVLT, Ray Auditory Verbal Learning Test; TMTA, Trail Making Test Version A; TMTB, Trail Making Test Version B; VR, visual reproduction; WMI-WAIS, Working Memory Index from the Wechsler Adult Intelligence Scale; WMS, Wechsler Memory Scale.

###### 

Summary of case series reported

  Reference                                    Number of patients   TS symptoms improvement            Motor improvement   Aphasia improvement           Hemineglect improvement   Cognitive improvement   Functional evaluation
  -------------------------------------------- -------------------- ---------------------------------- ------------------- ----------------------------- ------------------------- ----------------------- ----------------------------
  Grant and Norcross[@b12-ndt-10-695]          83 (43 with TS)      11 (25%)                           6 (14%)             --                            --                        3 (7%) unspecified      --
  Grantham and Landis[@b15-ndt-10-695]         100 (54 with TS)     16 (29%)                           --                  Referred but not quantified   --                        --                      --
  Tabaddor and LaMorgese[@b16-ndt-10-695]      Case report          --                                 Positive            --                            --                        --                      Dynamic brain scan
  Yamaura and Makino[@b13-ndt-10-695]          33 (29 with TS)      --                                 9 (31%)             --                            --                        --                      CSF pressure and EEG
  Nakamura et al[@b34-ndt-10-695]              Case report          Positive                           Positive            Positive                      --                        --                      EEG
  Fodstad et al[@b20-ndt-10-695]               40                   22 (55%)                           --                  --                            --                        --                      CSF infusion test
  Richaud et al[@b27-ndt-10-695]               40 (15 with TS)      --                                 8 (53%)             1 (6%)                        --                        --                      Xe133 inhalation
  Segal et al[@b22-ndt-10-695]                 Case report          --                                 Positive            --                            --                        --                      --
  Ng and Dan[@b35-ndt-10-695]                  Case report          --                                 Positive            --                            --                        --                      --
  Schiffer et al[@b36-ndt-10-695]              5                    Headache improvement in one case   4 (80%)             --                            --                        --                      --
  Winkler et al[@b24-ndt-10-695]               13                   --                                 7 (53%)             2 (15%)                       2 (15%)                   7 (53%) unspecified     PET and TCD
  Gottlob et al[@b43-ndt-10-695]               Case report          Positive                           Positive            --                            --                        Positive, unspecified   --
  Erdogan et al[@b33-ndt-10-695]               18                   14 (77%)                           5 (27%)             --                            --                        --                      TCD
  Sugiyama et al[@b44-ndt-10-695]              Case report          Positive                           Positive                                          Positive                  Positive                SPECT
  Kuo et al[@b23-ndt-10-695]                   13                   --                                 8 (61%)             --                            --                        --                      TCD
  Isago et al[@b25-ndt-10-695]                 Case report          Positive                           Positive            Positive                      --                        --                      Xenon CT
  Kumar et al[@b37-ndt-10-695]                 Case report          --                                 Positive            --                            --                        --                      --
  Maeshima et al[@b26-ndt-10-695]              Case report          --                                 --                  --                            Present                   Positive, unspecified   SPECT
  Sakamoto et al[@b29-ndt-10-695]              Case report          --                                 Positive            --                            --                        --                      Perfusion CT
  Chieregato[@b38-ndt-10-695]                  Case report          Positive                           Positive            Positive                      --                        --                      --
  Bijlenga et al[@b42-ndt-10-695]              Case report          Positive                           Positive (tremor)   --                            --                        --                      Brainstem evoked potential
  Han et al[@b39-ndt-10-695]                   Case report          --                                 --                  --                            --                        Positive, unspecified   --
  Stiver et al[@b14-ndt-10-695]                38                   --                                 10 (26%)            --                            --                        --                      Perfusion CT (two cases)
  Joseph and Reilly[@b40-ndt-10-695]           Case report          --                                 Positive            --                            --                        --                      --
  Kemmling et al[@b30-ndt-10-695]              Case report          --                                 Positive            --                            --                        --                      MR perfusion
  Sarov et al[@b41-ndt-10-695]                 27 (7 with TS)       3 (11%)                            1 (3%)              --                            --                        --                      --
  Mokri[@b49-ndt-10-695]                       Case report          Positive                           Positive            --                            --                        Positive                --
  de Quintana-Schmidt et al[@b50-ndt-10-695]   Case report          Positive                           Positive            Positive                      --                        --                      --
  Carota et al[@b51-ndt-10-695]                Case report          --                                 --                  --                            --                        Positive                --

**Abbreviations:** CSF, cerebrospinal fluid; CT, computed tomography; EEG, electroencephalography; PET, positron emission tomography; SPECT, single-photon emission computed tomography; TCD, transcranial Doppler ultrasonography; TS, trephine syndrome.
